CD38 and acute myeloid leukemia: Nevertheless, in AML, CD45RA may be the most interesting LSC marker as its combination with CD34, CD38 and CD90 allows to estimate these cells at diagnosis and follow up by multiparametric flow cytometry (16, 32).